JRP
SGMT icon

Jasper Ridge Partners’s Sagimet Biosciences SGMT Stock Holding History

Jasper Ridge Partners’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.4K Hold
12,865
– – ﹤0.01% 147
2026
Q1 		$67.2K Hold
12,865
– – ﹤0.01% 139
2025
Q4 		$76.2K Sell
12,865
-6,135
-32% -$44.1K ﹤0.01% 136
2025
Q3 		$130K Hold
19,000
– – ﹤0.01% 138
2025
Q2 		$145K Hold
19,000
– – ﹤0.01% 138
2025
Q1 		$61.9K Buy
+19,000
New +$79.7K ﹤0.01% 140

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Jasper Ridge Partners's SGMT Position: Q2 2026 in Review

Jasper Ridge Partners held its Sagimet Biosciences (SGMT) position steady in Q2 2026 at 12,865 shares worth $99.4K. The position accounts for ﹤0.01% of the portfolio, ranked #147.

Jasper Ridge Partners first reported a position in SGMT in Q1 2025 and has held it in 6 quarters since. The position peaked at $145K in Q2 2025. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Jasper Ridge Partners held 12,865 shares of Sagimet Biosciences worth $99.4K as of Q2 2026.
  • Jasper Ridge Partners left its Sagimet Biosciences share count unchanged in Q2 2026.
  • Sagimet Biosciences made up ﹤0.01% of Jasper Ridge Partners's portfolio in Q2 2026, its #147 holding.
  • Jasper Ridge Partners first reported a position in Sagimet Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Jasper Ridge Partners's Sagimet Biosciences position peaked at $145K in Q2 2025.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Jasper Ridge Partners's 13F filing for Q2 2026, filed 13 Aug 2026.